Patricia Novoa-Vogt, APRN
Nurse Practitioner · Miami, FLNPI 1801375753
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 65.6% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $17,981, more than ten times the $1,563 reported in 2021. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $229.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$23K
- Seagen Inc.$5K
- Immunogen, Inc.$4K
- GSK$1K
- Genmab U.S., Inc.$735
- Myriad Genetic Laboratories, Inc.$280
- plus $1K from 10 others
What the payments were for
- Consulting fees$9,98928%
- Speaking & faculty fees$13,52838%
- Travel & lodging$6,62219%
- Food & beverage$5,27315%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $23,235 |
| Seagen Inc. | 10 | $4,640 |
| Immunogen, Inc. | 13 | $3,989 |
| GSK | 36 | $1,429 |
| Genmab U.S., Inc. | 1 | $735 |
| Myriad Genetic Laboratories, Inc. | 5 | $280 |
| Eisai Inc. | 2 | $245 |
| AstraZeneca | 3 | $241 |
| Merck | 5 | $204 |
| Pfizer | 1 | $118 |
| Johnson & Johnson(2 entities) | 3 | $103 |
| Sumitomo Pharma America, Inc. | 3 | $67 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Astellas Pharma US Inc | 2 | $35 |
| Beone Medicines USA, Inc. | 1 | $17 |
| Clovis Oncology, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$35,412 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 12 | $171 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $153 |
| Ondansetron Hcl | 18 | $126 |
| Prochlorperazine Maleate | 13 | $83 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Miami
- Margarita FernandezMiami$311K
- Maya BloombergMiami$202K
- Haydee KapinMiami$97K
- Terri PollackMiami$59K
- Moriane JosephMiami$23K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.